Biotheus Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 300

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $290M

  • Investors
  • 1

Biotheus General Information

Description

Developer of next generation antibody-based therapeutics. The company studies the mechanisms of TReg cells and innate immunity in cancer, discovers antibody and develops antibody-based therapeutics, enabling patients to have more efficient immunity therapy and drugs for cancer and metabolic diseases.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Unit 10B, Building 4, No. 1 Keji 7th Road
  • Xiang Zhou District, Tangjiawan Town
  • Zhuhai, Guangdong 519080
  • China
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Discovery
Acquirer
Vertical(s)
Corporate Office
  • Unit 10B, Building 4, No. 1 Keji 7th Road
  • Xiang Zhou District, Tangjiawan Town
  • Zhuhai, Guangdong 519080
  • China

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Biotheus Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 31-Jan-2025 $290M Completed Generating Revenue
4. Early Stage VC 03-Mar-2021 Completed Generating Revenue
3. Early Stage VC (Series B) 30-Sep-2020 Completed Generating Revenue
2. Early Stage VC 26-Jun-2019 $14.5M $40.5M Completed Generating Revenue
1. Early Stage VC (Series A) 29-Oct-2018 $26.1M $26.1M Completed Generating Revenue
To view Biotheus’s complete valuation and funding history, request access »

Biotheus Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of next generation antibody-based therapeutics. The company studies the mechanisms of TReg cells and innate im
Biotechnology
Zhuhai, China
300 As of 2025

San Po Kong, Hong Kong
 

Shanghai, China
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Biotheus Competitors (3)

One of Biotheus’s 3 competitors is LakeShore Biopharma, a Formerly PE-Backed company based in San Po Kong, Hong Kong.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
LakeShore Biopharma Formerly PE-Backed San Po Kong, Hong Kong
Regor Therapeutics Venture Capital-Backed Shanghai, China
Clover Biopharmaceuticals Formerly VC-backed Shanghai, China
You’re viewing 3 of 3 competitors. Get the full list »

Biotheus Patents

Biotheus Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026017189-A2 Anti-il-31 antibody, pharmaceutical composition thereof and use thereof Pending 19-Jul-2024
WO-2026017189-A3 Anti-il-31 antibody, pharmaceutical composition thereof and use thereof Pending 19-Jul-2024
WO-2026017190-A1 Anti-il-4rα single-domain antibody, fusion protein thereof, pharmaceutical composition thereof and use thereof Pending 19-Jul-2024
WO-2026017191-A2 Anti-il-5 antibody, pharmaceutical composition thereof and use thereof Pending 19-Jul-2024
WO-2026017191-A3 Anti-il-5 antibody, pharmaceutical composition thereof and use thereof Pending 19-Jul-2024
To view Biotheus’s complete patent history, request access »

Biotheus Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Biotheus Former Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
CPE Funds Management PE/Buyout Minority
Cowin Capital Venture Capital Minority
General Atlantic Growth/Expansion Minority
Hanne Capital Growth/Expansion Minority
Highlight Capital Venture Capital Minority
You’re viewing 5 of 11 investors. Get the full list »

Biotheus FAQs

  • When was Biotheus founded?

    Biotheus was founded in 2018.

  • Where is Biotheus headquartered?

    Biotheus is headquartered in Zhuhai, China.

  • What is the size of Biotheus?

    Biotheus has 300 total employees.

  • What industry is Biotheus in?

    Biotheus’s primary industry is Biotechnology.

  • Is Biotheus a private or public company?

    Biotheus is a Private company.

  • What is the current valuation of Biotheus?

    The current valuation of Biotheus is .

  • What is Biotheus’s current revenue?

    The current revenue for Biotheus is .

  • How much funding has Biotheus raised over time?

    Biotheus has raised $40.5M.

  • Who are Biotheus’s investors?

    CPE Funds Management, Cowin Capital, General Atlantic, Hanne Capital, and Highlight Capital are 5 of 11 investors who have invested in Biotheus.

  • Who are Biotheus’s competitors?

    LakeShore Biopharma, Regor Therapeutics, and Clover Biopharmaceuticals are competitors of Biotheus.

  • When was Biotheus acquired?

    Biotheus was acquired on 31-Jan-2025.

  • Who acquired Biotheus?

    Biotheus was acquired by BioNTech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process